Concepedia

Author

Rika Koga

Daiichi-Sankyo (Japan)

Also Known As

Rika Koga

6

Publications

181

Citations

5

H-Index

20

Concepts

All Affiliations

Daiichi-Sankyo (Japan)National Institute of Infectious DiseasesDaiichi Sankyo (Germany)University of Tokyo HospitalTokyo University of Science
RK

About

Rika Koga is an author at Daiichi-Sankyo (Japan) specializing in hiv, molecular biology, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Natural Sciences

4

4

169

2

Biochemistry

4

4

169

3

Medicine

3

3

117

4

Biomolecular Engineering

3

3

154

5

Chemical Biology

2

2

106

Rika Koga

×

5

Publications

180

Citations

5

H-Index

YearCitations

Biologically Active Oligodeoxyribonucleotides. 5. 5‘-End-Substituted d(TGGGAG) Possesses Anti-Human Immunodeficiency Virus Type 1 Activity by Forming a G-Quadruplex Structure

Hitoshi Hotoda, Makoto Koizumi, Rika Koga,

Journal of Medicinal Chemistry

1998

91

Biologically active oligodeoxyribonucleotides—IX.1 Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3′- and 5′-end-modification

Makoto Koizumi, Rika Koga, Hitoshi Hotoda,

Bioorganic & Medicinal Chemistry

1997

41

Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3′- and 5′-end-modification, with anti-HIV-1 activity

Makoto Koizumi, Rika Koga, Hitoshi Hotoda,

Bioorganic & Medicinal Chemistry

1998

22

Biologically Active Oligodeoxyribonucleotides - IV: Anti-HIV-1 Activity of Tgggag Having Hydrophobic Substituent at Its 5′-End via Phosphodiester Linkage

Hitoshi Hotoda, Makoto Koizumi, Rika Koga,

Nucleosides and Nucleotides

1996

15

Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288

Toshinori Agatsuma, Kohji Abe, Hidehiko Furukawa,

Antiviral Research

1997

11

Page 1